Clinical Trial Update: A Study of JR-141 in Patients With Mucopolysaccharidosis II [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for JR-141 in Mucopolysaccharidosis II has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Ii

Drugs mentioned

• JR-141

Snippet

Sponsor: JCR Pharmaceuticals Co., Ltd. | Conditions: Mucopolysaccharidosis II | Phase 2, Phase 3 | Status: COMPLETED